Table 4.
Adverse events during follow-up
| Patients (gender, age) | Months in follow-up before termination | Cause of termination |
| Male, 52 | 9 | Relapsing angina*, CCS III |
| Male, 70 | 11 | Withdrawal from follow-up |
| Male, 64 | 9 | Relapsing angina*, CCS III |
| Male, 71 | 10 | Relapsing angina*, CCS III |
| Male, 66 | 9 | Relapsing angina*, CCS IV |
| Male, 62 | 8 | Relapsing angina*, CCS III |
| Male, 73 | 14 | Relapsing angina*, CCS III |
| Male, 53 | 12 | Relapsing angina*, CCS III |
| Male, 57 | 10 | Relapsing angina*, CCS III |
| Male, 74 | 20 | Death due to pneumonia and cardiac failure |
| Male, 71 | 10 | Relapsing angina*, CCS III |
| Male, 71 | 4 | Death of unknown causes |
| Female, 79 | 14 | Death due to amyloidosis |
| Male, 71 | 21 | Relapsing angina*, CCS III |
* = Patients with relapsing angina pectoris in need of further therapy during the follow-up. CCS = Canadian Cardiovascular Society classification.